dc.creatorCarrasco-Gallardo, Carlos
dc.creatorFarías, Gonzalo A.
dc.creatorFuentes, Patricio
dc.creatorCrespo, Fernando
dc.creatorMaccioni Baraona, Ricardo
dc.date.accessioned2019-03-15T16:03:40Z
dc.date.available2019-03-15T16:03:40Z
dc.date.created2019-03-15T16:03:40Z
dc.date.issued2012
dc.identifierArchives of Medical Research, Volumen 43, Issue 8, 2018, Pages 699-704
dc.identifier01884409
dc.identifier18735487
dc.identifier10.1016/j.arcmed.2012.10.010
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165883
dc.description.abstractAlzheimer's disease (AD) is a brain disorder displaying a prevalence and impact in constant expansion. This expansive and epidemic behavior is concerning medical and public opinion while focusing efforts on its prevention and treatment. One important strategy to prevent this brain impairment is based on dietary changes and nutritional supplements, functional foods and nutraceuticals. In this review we discuss the potential contributions of shilajit and complex B vitamins to AD prevention. We analyze the status of biological studies and present data of a clinical trial developed in patients with mild AD. Studies suggest that shilajit and its active principle fulvic acid, as well as a formula of shilajit with B complex vitamins, emerge as novel nutraceutical with potential uses against this brain disorder. © 2012 IMSS.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceArchives of Medical Research
dc.subjectAlzheimer's disease
dc.subjectFulvic acid
dc.subjectFunctional foods
dc.subjectNutraceuticals
dc.subjectShilajit
dc.subjectTau protein
dc.titleCan Nutraceuticals Prevent Alzheimer's Disease? Potential Therapeutic Role of a Formulation Containing Shilajit and Complex B Vitamins
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución